Ticogrelor monotherapy post PCI associated with similar rates of revascularization as duel antiplatelet therapy
New insights from the TWILIGHT trial showed that ticagrelor monotherapy after three months of ticagrelor plus aspirin was associated with similar rates of recurrent coronary revascularization, major adverse cardiac and cerebrovascular ...
May 20, 2023
0
2